Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 01-2026 | 10-2025 | 07-2025 | 04-2025 | 01-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,031 | -15,778 | -8,360 | 30,656 | 18,907 |
| Accounts payable and accrued liabilities | 715 | 536 | 66 | 10 | 96 |
| Other Working Capital | -846 | -2,043 | 3,877 | 3,724 | 99 |
| Other Operating Activity | 11,402 | 14,312 | 2,423 | -37,368 | -21,039 |
| Operating Cash Flow | $-3,760 | $-2,974 | $-1,994 | $-2,978 | $-1,938 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 2,000 | -3,000 | 0 | -7,000 | -7,000 |
| Investing Cash Flow | $2,000 | $-3,000 | $N/A | $-7,000 | $-7,000 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,047 | N/A | N/A | N/A | N/A |
| Common Stock Repurchased | -402 | N/A | N/A | -2,542 | -2,371 |
| Dividend Paid | -163 | -61 | N/A | N/A | N/A |
| Other Financing Activity | 6,269 | 6,269 | 0 | -22,487 | -22,487 |
| Financing Cash Flow | $6,751 | $6,208 | $N/A | $-25,029 | $-24,858 |
| Exchange Rate Effect | 2 | 0 | 0 | 0 | -1 |
| Beginning Cash Position | 15,172 | 15,172 | 15,172 | 50,180 | 50,180 |
| End Cash Position | 20,166 | 15,406 | 13,178 | 15,172 | 16,384 |
| Net Cash Flow | $4,993 | $234 | $-1,994 | $-35,008 | $-33,797 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,760 | -2,974 | -1,994 | -2,978 | -1,938 |
| Free Cash Flow | -3,760 | -2,974 | -1,994 | -2,978 | -1,938 |